China Grapples with HMPV Surge as Viral Infections Strain Healthcare System

China is currently witnessing a rise in Human Metapneumovirus (HMPV) infections, sparking concerns of another health crisis after the COVID-19 pandemic. Reports and online discussions indicate widespread transmission, with some alleging that hospitals and crematoriums are overwhelmed. Circulating videos depict overcrowded medical facilities, and social media users mention the concurrent spread of influenza A, HMPV, Mycoplasma pneumoniae, and COVID-19. Some accounts link the increase in HMPV infections to a rise in deaths, particularly among individuals aged 40 to 80.

The Chinese Center for Disease Control and Prevention (CDC) has reportedly observed an uptick in HMPV-positive cases, particularly among children aged 14 and under.

Neither Chinese health authorities nor the World Health Organization (WHO) have validated claims of an epidemic or emergency declaration.

HMPV, first identified in 2001, belongs to the Pneumoviridae family, which also includes respiratory syncytial virus (RSV). Research indicates it has circulated in humans for over six decades. The virus primarily causes respiratory illnesses and poses the greatest risk to young children, older adults, and individuals with weakened immune systems.

The WHO has reiterated its call for transparency from China regarding the origins of COVID-19. In a statement issued Monday, the organisation emphasised, “We continue to call on China to share data and provide access to help us understand the origins of COVID-19. This is a moral and scientific imperative.” The WHO further warned that without global transparency, data sharing, and cooperation, the world remains unprepared to effectively prevent and respond to future epidemics and pandemics.